IMMIX BIOPHARMA, INC. (IMMX) Operating cash flow 2020–2025
IMMIX BIOPHARMA, INC. (IMMX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.9MFY2025 · since FY2020: -$404,694 → -$23.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.9M | -64.0% |
| FY2024 | -$14.6M | -28.3% |
| FY2023 | -$11.4M | -53.5% |
| FY2022 | -$7.4M | -366.1% |
| FY2021 | -$1.6M | -292.7% |
| FY2020 | -$404,694 | — |
Source: SEC XBRL filings · For reference only · Not investment advice